Strengthening the European translational research ecosystem for advanced therapy medicinal products (ATMPs) for rare diseases

This section details the eligible entities and geographical scope of the funding program, along with its core objectives to advance rare disease treatments. The program targets a broad spectrum of organizations and individuals across Europe, emphasizing collaborative research and innovation in advanced therapies.

This section outlines the types of projects, thematic areas, and developmental stages eligible for funding. It focuses on innovative research and development in advanced therapies, with a strong emphasis on addressing current bottlenecks and improving processes for rare disease treatments.

This section details the nature of financial support provided by the program, including the type of instrument, funding amounts, and expected project duration. The program primarily offers grants to support ambitious research and innovation initiatives.

This section outlines the essential conditions, regulations, and stipulations that applicants and beneficiaries must adhere to throughout the application and project implementation phases. These cover legal, administrative, and ethical aspects to ensure fair and compliant participation.

The application process for this program involved a single-stage submission followed by a comprehensive evaluation. Applicants were required to prepare detailed proposals using specific templates and adhere to strict submission guidelines.

This section outlines the foundational legal and official documents that authorize, establish, and govern the funding program, ensuring transparency and adherence to European Union regulations.